Viking Therapeutics (VKTX) surges on promising obesity drug results. Explore key price levels and analyst insights in this detailed analysis.

Viking Therapeutics stock is volatile Monday after the pharma company released positive data for its weight-loss drug. Here's ...

TPG's Ashley Kosciolek accepted a free trip from Viking Cruises to sail on Viking Mississippi. The opinions expressed below ...

The biotech had tested the oral asset, dubbed VK2735, at doses ranging from 2.5 mg up to 100 mg. Viking already revealed back in March that 25% of the eight patients who received 20-mg doses saw their ...

Ship-shaped graves have been identified at the site, which came to light during investigations of an earlier Stone Age ...

Viking Therapeutics shares surge as VK2735 shows significant ... At the same time, the forecast for gross fee revenues was ...

The sprawling Eustis spread includes a 10,000-square-foot residence and two barns, one for horses and the other with a ...

On Tuesday, Viking Therapeutics Inc (VKTX) stock saw a modest uptick, ending the day at $64.63 which represents a slight increase of $1.49 or 2.36% from the prior close of $63.14. The stock opened at ...

The Valley City State University women’s basketball team suffered its first defeat of the season after an 86-51 loss to Briar ...

German-born DJ and producer Lilly Palmer is a techno trailblazer, and has been bringing impassioned sets to the global stage ...

Viking Therapeutics' highly anticipated weight-loss pill topped Wall Street's expectations — and a rival pill from Novo ...